| Literature DB >> 21080125 |
Kenji Ishitsuka1, Hiroo Katsuya, Tomona Toyota, Masanao Ishizu, Naoko Kunami, Mana Fujita, Hidenori Sasaki, Yasushi Takamatsu, Masanobu Uchiyama, Haruo Fujikane, Kentaro Ogata, Shuuji Hara, Kazuo Tamura.
Abstract
Combination therapy with interferon-α and zidovudine (IFN/AZT) has been regarded as standard care for acute and indolent (i.e., chronic and smouldering) ATL based on reports involving a limited number of patients. This treatment approach has not been evaluated in Japan, a major endemic area of this disease in the world. This is the first Japanese report of IFN/AZT for ATL. It is impossible to draw any definitive conclusion from this small study; however, IFN/AZT showed clear anti-ATL effects for refractory/relapsed ATL patients. This report would contribute for developing future ATL treatment in Japan.Entities:
Mesh：
Substances：
Year: 2010 PMID： 21080125 DOI： 10.1007/s12185-010-0717-3
Source DB: PubMed Journal: Int J Hematol ISSN： 0925-5710 Impact factor: 2.490